MediXall (MDXL) Gross Profit (2022 - 2024)
MediXall's Gross Profit history spans 3 years, with the latest figure at $22300.0 for Q3 2024.
- For Q3 2024, Gross Profit rose 819.59% year-over-year to $22300.0; the TTM value through Sep 2024 reached $174367.0, up 270.43%, while the annual FY2023 figure was $72913.0, 23.02% up from the prior year.
- Gross Profit reached $22300.0 in Q3 2024 per MDXL's latest filing, down from $38252.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $67731.0 in Q1 2024 to a low of -$11535.0 in Q1 2023.
- Average Gross Profit over 3 years is $23678.5, with a median of $20766.0 recorded in 2022.
- Peak YoY movement for Gross Profit: tumbled 245.88% in 2023, then surged 819.59% in 2024.
- A 3-year view of Gross Profit shows it stood at $20243.0 in 2022, then soared by 127.65% to $46084.0 in 2023, then tumbled by 51.61% to $22300.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Gross Profit are $22300.0 (Q3 2024), $38252.0 (Q2 2024), and $67731.0 (Q1 2024).